Business Context and Reporting Period
Company: Landec Corporation (Note: Metadata referenced "LIFECORE BIOMEDICAL, INC." but the filing text is for Landec Corporation, ticker LNDC).
Reporting Period: Fiscal year ended May 31, 2009.
Business Overview: Landec designs, develops, and sells temperature-activated specialty polymer products. Operations are divided into three core segments:
- Food Products Technology: Operated through subsidiary Apio, Inc., utilizing proprietary BreatheWay packaging for fresh-cut and whole produce to extend shelf life.
- Commodity Trading: Buy-sell business for whole fruit and vegetable products, primarily exporting to Asia and selling domestically to Wal-Mart.
- Technology Licensing: Licensing of Intellicoat seed coating technology (primarily to Monsanto) and Intelimer polymers for industrial and personal care applications.
Key Financial Metrics
| Metric (in thousands) | Fiscal 2009 | Fiscal 2008 |
|---|---|---|
| Total Revenues | $235,938 | $238,527 |
| Gross Profit | $34,280 | $38,228 |
| Operating Income | $12,598 | $15,176 |
| Net Income | $7,730 | $13,542 |
| Diluted EPS | $0.29 | $0.50 |
| Cash and Cash Equivalents | $43,459 | $44,396 |
| Total Debt | $0 | $0 |
| Operating Cash Flow | $9,435 | $17,520 |
Margins: Gross margin decreased to approximately 14.5% in 2009 from 16.0% in 2008. Net income margin decreased to 3.3% from 5.7%.
Material Changes vs. Prior Period
- Revenue Decline: Total revenues decreased 1% to $235.9 million. The Food Products Technology segment saw a 2% decline, driven by a 1% drop in value-added unit sales and a 23% drop in Apio Packaging revenues due to amended minimum payments from Chiquita.
- Profitability Compression: Net income fell 43% to $7.7 million. This was driven by a 10% decrease in gross profit (due to higher raw material costs and lower packaging revenues) and a significant increase in the effective tax rate from 20% to 42% as the company utilized its net operating loss carryforwards.
- Segment Performance:
- Food Products Technology: Gross profit declined 16% to $23.4 million.
- Commodity Trading: Revenues remained flat, but gross profit increased 6% to $3.7 million due to a shift toward higher-margin vegetable products.
- Technology Licensing: Revenues increased 5% to $7.2 million, primarily from the Monsanto license agreement.
- Debt: The company terminated its $7.0 million revolving line of credit with Wells Fargo in May 2009. The company ended the period with no debt.
Guidance, Outlook, and Risks
Management Commentary & Outlook:
- Management expects capital expenditures of approximately $6.0 million to $6.5 million in fiscal 2010, primarily for a 40,000 square foot expansion of the Apio processing plant.
- The company believes its cash from operations and existing cash reserves are sufficient to finance requirements for at least the next twelve months.
- Future growth depends on the commercialization of new products, particularly in the fresh-cut produce market and the expansion of the Chiquita avocado packaging agreement.
Risks and Contingencies:
- Economic Conditions: The filing highlights risks associated with the economic slowdown, including reduced demand, conservative purchasing by customers, and potential credit issues for vendors and growers.
- Customer Concentration: The top five customers accounted for 46% of revenues, with Costco Wholesale Corporation alone representing 21%.
- Supply Chain: Dependence on single-source suppliers for certain raw materials (monomers) and single-location manufacturing for Apio (Guadalupe, CA) poses operational risks.
- Intellectual Property: Success depends on maintaining patent protection and avoiding infringement claims.
- Regulatory: Operations are subject to FDA, USDA, and environmental regulations. A determination that BreatheWay packaging is a food additive requiring FDA approval could materially impact the business.
Investor Verification Checklist
- Verify the sustainability of the 42% effective tax rate in future periods now that net operating loss carryforwards have been utilized.
- Monitor the performance of the Chiquita licensing agreement, specifically the minimum gross profit thresholds for bananas and avocados.
- Assess the impact of the 21% revenue concentration with Costco Wholesale Corporation on future pricing power and volume stability.
- Review the progress of the Apio facility expansion and its impact on capacity and capital expenditure burn rate.
- Confirm the status of the Monsanto license agreement regarding the potential $10 million purchase option for Landec Ag.